IL104150A - Pharmaceutical compositions comprising a mao inhibitor and an uptake inhibitor and their preparation - Google Patents

Pharmaceutical compositions comprising a mao inhibitor and an uptake inhibitor and their preparation

Info

Publication number
IL104150A
IL104150A IL104150A IL10415092A IL104150A IL 104150 A IL104150 A IL 104150A IL 104150 A IL104150 A IL 104150A IL 10415092 A IL10415092 A IL 10415092A IL 104150 A IL104150 A IL 104150A
Authority
IL
Israel
Prior art keywords
inhibitor
preparation
pharmaceutical compositions
mao
uptake
Prior art date
Application number
IL104150A
Other languages
English (en)
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL104150A publication Critical patent/IL104150A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL104150A 1991-12-20 1992-12-18 Pharmaceutical compositions comprising a mao inhibitor and an uptake inhibitor and their preparation IL104150A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
PCT/HU1992/000060 WO1993012775A1 (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
IL104150A true IL104150A (en) 1997-11-20

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104150A IL104150A (en) 1991-12-20 1992-12-18 Pharmaceutical compositions comprising a mao inhibitor and an uptake inhibitor and their preparation

Country Status (27)

Country Link
US (1) US5589513A (xx)
EP (1) EP0617615A1 (xx)
JP (1) JPH07502730A (xx)
KR (1) KR940703655A (xx)
AU (1) AU677170B2 (xx)
BG (1) BG98827A (xx)
BR (1) BR9206950A (xx)
CA (1) CA2125776A1 (xx)
CZ (1) CZ147494A3 (xx)
EC (1) ECSP930933A (xx)
EE (1) EE03015B1 (xx)
FI (1) FI942932A (xx)
HU (2) HUT63579A (xx)
IL (1) IL104150A (xx)
LT (1) LT3119B (xx)
LV (1) LV10386B (xx)
MY (1) MY111055A (xx)
NO (1) NO942303D0 (xx)
NZ (1) NZ246384A (xx)
PH (1) PH31073A (xx)
PL (1) PL172048B1 (xx)
RO (1) RO115785B1 (xx)
RU (1) RU2125448C1 (xx)
SI (1) SI9200404A (xx)
SK (1) SK74494A3 (xx)
WO (1) WO1993012775A1 (xx)
ZA (1) ZA929883B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
CA2212412A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
EP0241809B1 (de) * 1986-04-16 1990-08-08 ASTA Pharma Aktiengesellschaft Synergistische Kombination von Amantadin und Selegilin
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
WO1993012775A1 (en) 1993-07-08
RU2125448C1 (ru) 1999-01-27
US5589513A (en) 1996-12-31
MY111055A (en) 1999-08-30
LT3119B (en) 1994-12-27
HU914060D0 (en) 1992-03-30
NO942303D0 (no) 1994-06-17
FI942932A0 (fi) 1994-06-17
CZ147494A3 (en) 1995-01-18
LV10386B (en) 1995-12-20
AU3265293A (en) 1993-07-28
PL172048B1 (pl) 1997-07-31
BR9206950A (pt) 1995-11-28
FI942932A (fi) 1994-06-17
LTIP249A (en) 1994-07-15
EE03015B1 (et) 1997-08-15
SK74494A3 (en) 1995-01-12
AU677170B2 (en) 1997-04-17
KR940703655A (ko) 1994-12-12
ZA929883B (en) 1994-05-16
RO115785B1 (ro) 2000-06-30
HU211478A9 (en) 1995-11-28
HUT63579A (en) 1993-09-28
JPH07502730A (ja) 1995-03-23
ECSP930933A (es) 1994-04-20
CA2125776A1 (en) 1993-07-08
PH31073A (en) 1998-02-05
SI9200404A (en) 1993-06-30
NZ246384A (en) 1996-02-27
BG98827A (en) 1995-06-30
LV10386A (lv) 1995-02-20
NO942303L (xx) 1994-08-17
EP0617615A1 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
IL104150A (en) Pharmaceutical compositions comprising a mao inhibitor and an uptake inhibitor and their preparation
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
HU9303143D0 (en) Pharmaceutical compositions
AU2157192A (en) 4-aminoquinolines and pharmaceutical compositions thereof
GB9319585D0 (en) Improvements in pharmaceutical compositions
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
IL98034A0 (en) Pharmaceutical compositions including ibuprofen and a prostaglandin
GB9100465D0 (en) Pharmaceutical compositions
GB2254252B (en) Pharmaceutical compositions comprising clozapine and a radical scavenger
GB9215188D0 (en) Polymerisable compositions
EP0525901A3 (en) Compositions containing a fluoroether and use thereof
GB9214757D0 (en) Pharmaceutical compositions
IL106214A0 (en) Thf-ypsilon2 analogs and pharmaceutical compositions comprising them
GB9120672D0 (en) Pharmaceutical compositions
IL97365A0 (en) Pharmaceutical compositions comprising a lymphokine
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
IL101998A0 (en) 6-o-alkylelsamicin a derivatives and pharmaceutical compositions containing them
GB9221212D0 (en) Pharmaceutical compositions
GB9200414D0 (en) Pharmaceutical compositions
IL107610A0 (en) A cytotoxic factor and derivatives thereof their preparation and compositions comprising them
IL116260A0 (en) Pharmaceutical compositions comprising a cytokine
IL114077A0 (en) Pharmaceutical compositions comprising a cytokine
CA67885S (en) Dice game counter
IL101997A0 (en) 6-o-acylelsamicin a derivatives and pharmaceutical compositions containing them
GB9124306D0 (en) Polymerisable compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void